SUI - The October CURSE | SUI Price Prediction
1 extracted signal · 0 resolved · 1 still active
Altcoin DoctorIndependent analyst profile- Source published
- 14 Oct 2026, 10:32 UTC
- Recorded by Tahlil Plus
- 14 Oct 2026, 14:11 UTC
AI-generated source summary
The analysis focuses on the SUI/USD trading pair, currently priced at $1.054, with a target of $2.39. The fail bound for this bullish prediction is set at $0.95, which would invalidate the upward trajectory. The broader market context is evaluated using the USDT.D chart, which indicates a bearish trend for the US Dollar's dominance against stablecoins. Historically, periods of declining USDT.D have coincided with bullish movements in altcoin market capitalization. The analysis highlights that the USDT.D often experiences a pullback in the first two weeks of October, followed by a significant double-digit percentage pump. This seasonal pattern suggests a potential bullish outlook for the altcoin market, including SUI. The overall crypto market cap, excluding Bitcoin, is observed to be bullish, with a strong upward trend predicted following consolidation. This supports the bullish thesis for SUI, anticipating a sharp rise towards the target price.
AI-generated summary based on the source content.
Signal outcomes at a glance
Tracking LiveSignals in this source
Evidence and evaluation progress
- Original source published
The analyst published the original source item.
- Source recorded by Tahlil Plus
The public source was preserved as the evidence record for this case.
- Market predictions extracted
1 eligible signal linked to this case.
- Outcome tracking started
Tahlil Plus began monitoring the extracted predictions.
- Source processing completed
Source analysis and structured extraction completed.
- Live evaluation in progress
1 signal remains active.
Altcoin Doctor
Platform-wide history, separate from this source evaluation.
Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.